See also this year's filing and all EDGAR filings for this company.
PDF Report 0001625288_2019_NEXIEN_BIOPHARMA_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001625288')"} |
Graph
Absolute values for 0001625288, NEXIEN BIOPHARMA INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 834,739 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 437,582 |
| 4 | LiabilitiesCurrent | 88,785 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 773,437 |
| 9 | ResearchAndDevelopmentExpense | 116,791 |
| 10 | remainder_Expenses | 392,969 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,272,321 |
| 1 | Liabilities | 88,785 |
| 2 | Expenses | 1,283,197 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 1,183,536 |
| 5 | NetIncome | -1,283,197 |
| 6 | ComprehensiveNetIncome | -1,283,197 |
| 7 | BaseVar | 1,322,152 |
| 8 | EconomicCapitalRatio | 1.11 |
Edgar->Model Mapping
Feature Distribution
Change over Time
